Clieck HERE to read our latest Open Briefing interview with Andrew McLellan https://www.asx.com.au/asxpdf/20190429/pdf/444lr6fnh6n4gh.pdf
You will always find the latest presentation and videos under the Company Overview page Download the March 2019 Broker Presentation Watch the Corpoporate Video updated this week: 26th of March 2019
In this Open Briefing®, Andrew discusses: • Four new OEM proposals under consideration • Growing market enquiries and successful trade shows including ISBER and SLAS • Six months trading results, period ended 31 December 2018 • Changing revenue mix to ongoing consumables sales • Increasing production and delivery under US$11.9m Labcon contract Open Briefing interview with MD Andrew McLellan. Download…
The “Pulmonary Biobank Consortium, CIBER of Respiratory Diseases (CIBERES) – ISCIII (Madrid), Institut d’Investigació Sanitària de les Illes Balears (IdISBA) – Hospital Universitari Son Espases, Mallorca, Spanish Biobank Network” recently presented a scientific poster about Bluechiip technology in the International Society of Biobanks and Environmental Repositories (ISBER) Symposium this February 2019 in Berlin. See CIBERES original news publication from the…
In this Open Briefing, Andrew discusses: Labcon’s official release and marketing of Bluechiip enabled product Accelerating sales and production scaling progress Reader production status and approvals Partner progress and cash position Download the full document here: https://www.asx.com.au/asxpdf/20190130/pdf/4425m31s7m9cnn.pdf
Download the presentation shown during the past AGM on the 26th of November 2018 https://www.asx.com.au/asxpdf/20181126/pdf/440mb0vpc9v670.pdf
Notice is given that the Annual General Meeting of the members of Bluechiip Limited will be held on Monday 26 of Nov 2018 at 10am. Location: Level 16, 333 Collins St, Melbourne, Vic, 3000 (offices of Phillips Ormonde Fitzpatrick). Download the ASX announcement in full here: https://www.asx.com.au/asxpdf/20181024/pdf/43zl1vfd331cpv.pdf
Watch the video: https://youtu.be/q64uGtuUwY4
In this Open Briefing, Andrew discusses: Recent #7.5M capital raise and the updated $15.9M over 3 yr Labcon agreement Recent customer activity and finalisation and product portfolio Recent 4C and cashflow forecast Partner and opportunity pipeline Read the full announcement here: https://www.asx.com.au/asxpdf/20181018/pdf/43zcy4f8442yrg.pdf
Read the full announcement here: https://www.asx.com.au/asxpdf/20181018/pdf/43zcy1zcj8cw0r.pdf